...
The objective of the Scheme is to maintain and improve the performance of BE testing laboratories involved in donor-screening in Europe, thereby thereby improving the safety safety of blood components and , plasma-derived medicinal products, organs, tissues and cells and protecting patients who receive blood transfusions.

